f
|
Recombinant Proteins
Expression, Purification, and Characterization
Starting with sequence data, CBI can design over-expression systems, and generate purified recombinant proteins for biopharmaceutical development and diagnostic applications. CBI can support drug and diagnostic development organizations from discovery to market. GLP and CLIA compliance with BSL-3 facilities.
View a printable PDF of this page
Please select a technology to find out more about our Recombinant Proteins services:
|
|